Stocks to Buy: A new listing has become Jefferies' latest 'high-conviction top pick'; Check upside targets

Molbio Diagnostics has successfully commercialized a differentiated point-of-care molecular diagnostics platform, Jefferies wrote in its note, adding that with two emerging…

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.cnbctv18.com)